Tramadol (Ultram) is prescribed for pain more than ever, with new recommendations to limit the use of opioid analgesics. Tramadol is a non-opioid that works on the opiate receptors. Unlike other opioids (like hydrocodone and codeine), tramadol doesn’t affect your breathing or heart. It’s a good option for trying to avoid opioids if NSAIDs (nonsteroidal anti-inflammatory drugs like ibuprofen and naproxen) aren’t recommended for you. See More
Ultram ER Latest News
Get the latest updates on this drug from the GoodRx medical team
Remember—effective Monday, August 18, 2014, tramadol (Ultram) and any products that contain tramadol, including Ultracet (tramadol/acetaminophen), Ultram ER (tramadol ER), or Conzip, will be considered schedule IV substances.
This means ANY medications containing tramadol will now have stricter rules for dispensing. This may affect your current prescription as well as your future prescriptions if you regularly take these medications. See More
The Drug Enforcement Administration (DEA) has officially declared tramadol (Ultram) a Class IV substance. This new scheduling will go into effect August 18, 2014 and means you will need a triplicate prescription to get tramadol. A scheduled drug is one whose use and distribution is tightly monitored.
Ultram (tramadol) is an opioid prescribed for moderate to severe pain in adults. It is different from some other medications that work the same way in that it is not currently considered a controlled substance (a DEA scheduled drug) in some states. However, regulations in Ohio are changing this fall.
One of the bright new changes in pain medications over the last few years were two medications: Ultram (tramadol) and now Nucynta (tapentadol). These are different from Vicodin (hydrocodone/acetaminophen), Percocet (oxycodone/acetaminophen), and Tylenol #3 (codeine/acetaminophen) in many ways and are considered much “gentler.” So, is Nucynta better? Lets look.
1. See More
Are they the same? What’s better? What is the prescription I have? It seems complicated but it’s not—let’s shed light on the common players: